RecruitingNot Applicable

The Clinical Outcomes and Prediction of Thermal Ablation for Low-risk Papillary Thyroid Carcinoma

China3,772 participantsStarted 2024-04-01

Plain-language summary

1. To evaluate the clinical outcomes of ultrasound-guided thermal ablation and thyroid surgery for the treatment of papillary thyroid carcinoma; 2. To develop and validate a artificial intelligence model to predict the outcomes of ultrasound-guided thermal ablation in the treatment of papillary thyroid carcinoma;

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. patients age between 18 and 80 year old, both sex
✓. papillary thyroid carcinoma confirmed by core-needle biopsy or fine-needle aspiration
✓. the largest diameter ≤2.0 cm
✓. no clinical or imaging evidences of extrathyroidal extension, lymph node metastasis and distant metastasis on ultrasound, nech and chest CT
✓. follow-up period ≥12 months,

Exclusion criteria

✕. patients with convincing evidence of aggressive papillary thyroid carcinoma or other type of thyroid cancer by biopsy
✕. history of neck radiation
✕. history of thyroid surgery
✕. coagulation disorder
✕. serious heart, respiratory, liver, or renal failure
✕. dysfunction of the vocal cord on the opposite side

What they're measuring

rate of disease progression

Timeframe: more than 5 year

Trial details

NCT IDNCT06316895

SponsorChinese PLA General Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-04-01

Contact for this trial

Lin Yan, MD

13811237313 gemma-y@163.com

View on ClinicalTrials.gov More Papillary Thyroid Cancer trials